The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(pyridin-2-ylmethylcarbamoyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)nicotinamide ID: ALA5285158
Max Phase: Preclinical
Molecular Formula: C21H20N4O2S
Molecular Weight: 392.48
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1sc2c(c1C(=O)NCc1ccccn1)CCCC2)c1cccnc1
Standard InChI: InChI=1S/C21H20N4O2S/c26-19(14-6-5-10-22-12-14)25-21-18(16-8-1-2-9-17(16)28-21)20(27)24-13-15-7-3-4-11-23-15/h3-7,10-12H,1-2,8-9,13H2,(H,24,27)(H,25,26)
Standard InChI Key: GQQVLRFJWVPNLD-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
1.5622 -0.0062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2769 0.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9888 -0.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9888 -0.8310 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2787 -1.2427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5622 -0.8347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8476 -1.2473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8476 -2.0726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1329 -0.8347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5816 -1.2473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5816 -2.0726 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.3858 -2.3227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8566 -1.6690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3646 -1.0014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5782 -0.2043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3752 0.0092 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9946 0.3791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2082 1.1762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6247 1.7597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8381 2.5570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2557 3.1382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5415 2.9245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7556 2.1318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1758 1.5451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7164 -3.0573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5181 -3.1382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9888 -2.4845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6582 -1.7499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
6 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
11 10 1 0
11 12 1 0
12 13 2 0
14 13 1 0
10 14 2 0
14 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
20 19 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
19 24 1 0
12 25 1 0
26 25 1 0
27 26 1 0
28 27 1 0
13 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 392.48Molecular Weight (Monoisotopic): 392.1307AlogP: 3.60#Rotatable Bonds: 5Polar Surface Area: 83.98Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.23CX LogP: 3.69CX LogD: 3.69Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -2.36
References 1. Wang KM, Ge YX, Zhang J, Chen YT, Zhang NY, Gu JS, Fang L, Zhang XL, Zhang J, Jiang CS.. (2023) New cycloalkyl[b]thiophenylnicotinamide-based α-glucosidase inhibitors as promising anti-diabetic agents: Synthesis, in silico study, in vitro and in vivo evaluations., 79 [PMID:36395995 ] [10.1016/j.bmcl.2022.129069 ]